ライフサイエンスコーパス: leukemia virus

1 fection of one cell line (DEL) with a murine leukemia virus.

2 RNAs packaged by a model retrovirus, murine leukemia virus.

3 ation and packaging domain of Moloney murine leukemia virus.

4 those of oncoretroviral RTs, such as murine leukemia virus.

5 n and also enhanced the production of murine leukemia virus.

6 onto unintegrated DNAs of the Moloney murine leukemia virus.

7 The etiology of human T cell leukemia virus 1 (HTLV-1)-mediated adult T cell leukemia

8 proviral integration site for Moloney murine leukemia virus 1 kinase (PIM-1).

9 Proviral Integration site for Moloney murine leukemia virus 1) has emerged as a key regulator of hypo

10 bly myelopathy induced by retrovirus human T leukemia virus-1 (HTLV-1).

11 proviral integration site for Moloney murine leukemia virus-1 (PIM-1), which in turn regulates NFkapp

12 zes the foreign Ag Tax from the human T cell leukemia virus-1 when presented by the class I MHC HLA-A

13 ink with the autoimmune disease human T cell leukemia virus-1-associated myelopathy/tropical spastic

14 reported that ectopic expression of Moloney leukemia virus 10 (MOV10) protein strongly inhibits retr

15 gh its interaction with RNA helicase Moloney leukemia virus 10 (MOV10).

16 Moloney leukemia virus 10, homolog (MOV10) is an IFN-inducible R

17 The Abelson murine leukemia virus (A-MuLV) expresses an alternative form of

18 A recent demonstration that the bovine leukemia virus, a retrovirus, uses RNA polymerase III to

19 ipeline, can identify integrations of murine leukemia virus, adeno-associated virus, Tol2 transposons

20 Based on previous studies of murine leukemia virus and HIV-1, we hypothesized that unpaired

21 ar to canonical retroviruses, such as murine leukemia virus and HIV.

22 e a high-resolution atlas of m(5)C in murine leukemia virus and reveal a functional role of m(5)C in

23 livery by wild-type ecotropic Moloney murine leukemia virus and vesicular stomatitis virus (VSV) G gl

24 to what extent virions of HERV-Kcon, murine leukemia virus, and HIV-1 have the ability to transduce

25 rived from three retroviruses (HIV-1, murine leukemia virus, and Mason-Pfizer monkey virus), two hepa

26 es blocked cytokine induction by HIV, murine leukemia virus, and simian immunodeficiency virus.

27 plication method for the detection of bovine leukemia virus antigen gp51.

28 The integration pattern of murine leukemia virus appears to be largely driven by regions t

29 V and the intensively studied Moloney murine leukemia virus, architectures of the regulatory domains

30 immunodeficiency (SCID-X1), a Moloney murine leukemia virus-based gamma-retrovirus vector expressing

31 virus infections: sheep infected with Bovine Leukemia Virus (BLV) and humans infected with Human T Ly

32 In contrast, bovine leukemia virus (BLV) expresses subgenomic RNAP III trans

33 Bovine leukemia virus (BLV) is a deltaretrovirus that infects d

34 arged residues in the deltaretrovirus bovine leukemia virus (BLV) matrix (MA) and NC domains affects

35 Here we demonstrate that the bovine leukemia virus (BLV), a retrovirus with an RNA genome, e

36 est that the leader region of Moloney murine leukemia virus contains inhibitory/regulatory sequences,

37 by reverse transcription via Moloney murine leukemia virus, degradation of chromosomal DNA with McrB

38 as the proto-oncogene from which the Abelson leukemia virus derived its Gag-v-Abl oncogene, recent re

39 uences in the 3' U3 region of Moloney murine leukemia virus-derived retroviral vectors.

40 EC3 does not catalyze base changes in murine leukemia virus DNA, it can be recovered from these virus

41 idly loaded onto unintegrated Moloney murine leukemia virus DNAs.

42 iple clonal integrations of ecotropic murine leukemia virus (E-MuLV).

43 Ecotropic, xenotropic, and polytropic mouse leukemia viruses (E-, X-, and P-MLVs) exist in mice as i

44 his hypothesis, infection of HIV-1 or murine leukemia virus Env (MLV-Env)-pseudotyped HIV-1 particles

45 defect in proteolytic cleavage of the murine leukemia virus Env cytoplasmic tail in pseudotyped virio

46 HIV-1, vesicular stomatitis virus, or murine leukemia virus Env glycoproteins.

47 The trimeric Moloney murine leukemia virus Env protein matures by two proteolytic cl

48 The membrane-proximal region of murine leukemia virus envelope (Env) is a critical modulator of

49 viral glycoproteins, including Friend murine leukemia virus envelope (F-MLV Env) are actively recruit

50 etherin and a viral glycoprotein, gibbon ape leukemia virus envelope (GaLV Env).

51 For murine leukemia virus envelope (MLV Env) glycoprotein, incorpor

52 For murine leukemia virus envelope (MLV Env) glycoprotein, incorpor

53 ing sequence of the ecotropic Moloney murine leukemia virus envelope glycoprotein with the peptide li

54 d how the protomeric units of Moloney murine leukemia virus envelope protein (Env) are activated in r

55 viral entry/infection of pseudotyped murine leukemia viruses expressing pathogenic NWA glycoproteins

56 rovirus glycoproteins, such as Friend murine leukemia virus (F-MLV) Env, but not with the related gib

57 e envelope glycoprotein of the Friend murine leukemia virus (F-MLV) ISD has been reported to abolish

58 ing viral spillover events.IMPORTANCE Feline leukemia virus (FeLV) can infect a variety of felid spec

59 While feline leukemia virus (FeLV) has been shown to infect felid spe

60 of FeLV infectious disease.IMPORTANCE Feline leukemia virus (FeLV) is a member of the genus Gammaretr

61 Feline leukemia virus (FeLV) is a naturally transmitted gammare

62 Feline leukemia virus (FeLV) is horizontally transmitted among

63 Feline leukemia virus (FeLV) is still a major cause of morbidit

64 RV-DC16), or can generate recombinant feline leukemia virus (FeLV).

65 exposure to gammaretroviruses such as feline leukemia viruses (FeLVs) occurs worldwide, but the basis

66 uses that infect human cells in vitro Feline leukemia viruses (FeLVs) rank high on this list, but nei

67 Lymph-borne Friend murine leukemia virus (FrMLV) exploits the sentinel macrophages

68 The retrovirus Friend murine leukemia virus (FrMLV) infects a subtype of B cells call

69 Gibbon ape leukemia virus (GALV) and koala retrovirus (KoRV) most l

70 Gibbon ape leukemia virus (GALV) and the koala retrovirus (KoRV) ar

71 LV) Env, but not with the related gibbon ape leukemia virus (GaLV) Env or with a chimeric F-MLV Env w

72 etrovirus-related virus (XMRV) or gibbon ape leukemia virus (GALV) infection, even when their respect

73 a close relative of KoRV and the gibbon ape leukemia virus (GALV), with virion morphology and Mn(2+)

74 The gibbon ape leukemia viruses (GALVs) are among the most medically re

75 Gibbon ape leukemia viruses (GALVs) are part of a larger group of p

76 e shown to restrict the expression of murine leukemia virus genomes but not retroviral genomes of the

77 parental wild-type ecotropic Moloney murine leukemia virus glycoprotein through the ecotropic recept

78 variants to promote the modified gibbon ape leukemia virus glycoprotein-pseudotyped lentiviral vecto

79 coproteins and also with modified gibbon ape leukemia virus glycoproteins.

80 Human T-cell leukemia virus (HTLV) type 1, the etiological agent of a

81 overed the antisense protein of human T-cell leukemia virus (HTLV) type 2 (APH-2), whose messenger RN

82 trate that driver mutations for human T-cell leukemia virus (HTLV)-associated adult T-cell leukemia l

83 and partial characterization of human T-cell leukemia virus (HTLV; now known as HTLV-1) produced by a

84 , human immunodeficiency virus, human T cell leukemia virus, human papilloma virus, hepatitis B and C

85 ic resonance structure of the Moloney murine leukemia virus IN (M-MLV) C-terminal domain (CTD) and a

86 SRP1 reduces HIV-1 infection, but not Murine Leukemia Virus, in human CD4(+) T cells.

87 In murine leukemia virus-induced myeloid leukemia in mice, integra

88 We found a previously unknown murine leukemia virus infection in one cell line.

89 oes not cause acute leukemia on its own, and leukemia virus insertion frequencies predict that RASGRP

90 The B-lymphoma Moloney murine leukemia virus insertion region-1 protein (BMI1) acts as

91 bidopsis thaliana) B lymphoma Moloney murine leukemia virus insertion region1 homolog (BMI1) POLYCOMB

92 nfirmed that the transcription factor Friend leukemia virus integration 1 (Fli-1) is a target of miR-

93 The ETS factor Friend leukemia virus integration 1 (FLI1) is a key modulator o

94 Friend leukemia virus integration 1 (FLI1), a critical transcri

95 Friend leukemia virus integration 1 (FLI1), an Ets transcriptio

96 B-cell-specific Moloney murine leukemia virus integration site 1 (BMI1) is a component

97 We generated murine leukemia virus integrations in human HepG2 and K562 cell

98 Injection of the LP-BM5 murine leukemia virus into mice causes murine AIDS, a disease c

99 some conservation between murine and feline leukemia viruses is crucial for activity.

100 Replication of the murine leukemia viruses is strongly suppressed in mouse embryon

101 of proviral insertion site of Moloney murine leukemia virus kinases (Pim-1, -2, and -3) in cancers, p

102 d thrombopoietin/cellular myeloproliferative leukemia virus liganding is dispensable for definitive t

103 Moloney murine leukemia virus-like particles (M-VLPs) were complexed wi

104 Non-infectious murine leukemia virus-like particles (M-VLPs) were electrostati

105 In the case of the ecotropic Moloney murine leukemia virus (M-MLV), the Nef-like effect is mediated

106 The Env protein of murine leukemia virus matures by two cleavage events.

107 Bovine leukemia virus microRNAs are strongly expressed in prele

108 dispensable for in vivo infectivity, bovine leukemia virus microRNAs represent approximately 40% of

109 release of HIV-1, as well as that of murine leukemia virus (MLV) and Ebola virus (EBOV); knockdown o

110 We demonstrate that murine leukemia virus (MLV) and human immunodeficiency virus (H

111 gene of gammaretroviruses, including murine leukemia virus (MLV) and xenotropic murine leukemia viru

112 Using the murine leukemia virus (MLV) as a model retrovirus, we have prev

113 Remarkably, although Moloney leukemia virus (MLV) assembles in the cytoplasm, precurs

114 nvelope protein (Env) from the CasBrE murine leukemia virus (MLV) can cause acute spongiform neurodeg

115 Murine leukemia virus (MLV) can efficiently spread in tissue cu

116 eins previously identified to inhibit murine leukemia virus (MLV) demonstrated an ability to induce N

117 gamma-Retroviral murine leukemia virus (MLV) DNA integration into the host genom

118 p between two recent additions to the murine leukemia virus (MLV) ecotropic subgroup: Mus cervicolor

119 It is not known if murine leukemia virus (MLV) encodes a Vif-like protein.

120 The glycoprotein murine leukemia virus (MLV) Env can readily form pseudotyped pa

121 generated chimeric constructs between murine leukemia virus (MLV) Gag and HBV Core to determine if th

122 The p12 protein of murine leukemia virus (MLV) Gag is associated with the preinteg

123 Here, we show that murine leukemia virus (MLV) has a unique means of counteracting

124 Murine leukemia virus (MLV) has been studied as one of the clas

125 eping Beauty (SB) transposons and the murine leukemia virus (MLV) in mouse embryonic stem cells (ESCs

126 ptide sequence from the C terminus of murine leukemia virus (MLV) IN.

127 tly affects HIV-1 replication but not murine leukemia virus (MLV) infection and that miR-128 modulati

128 We report alterations to the murine leukemia virus (MLV) integrase (IN) protein that success

129 rstanding the molecular mechanisms of murine leukemia virus (MLV) integration into host chromatin is

130 nd that the preintegration complex of murine leukemia virus (MLV) interacts with the dynein complex a

131 Murine leukemia virus (MLV) p12, encoded within Gag, binds the

132 ron-alpha-responsive manner, captures murine leukemia virus (MLV) particles and mediates their transf

133 this glycoprotein is compatible with murine leukemia virus (MLV) particles but incompatible with hum

134 iciencies of restriction of HIV-1 and murine leukemia virus (MLV) particles containing various propor

135 ious anemia virus (EIAV), or N-tropic murine leukemia virus (MLV) postentry and supported late HIV-1

136 cosylated Gag (glycoGag) protein of a murine leukemia virus (MLV) similarly enhance the infectiousnes

137 , we engineered a fluorescent Moloney murine leukemia virus (MLV) system consisting of MLV-integrase

138 ated by measuring the cleavage of the murine leukemia virus (MLV) transmembrane Env protein by the vi

139 Using a murine leukemia virus (MLV) variant with an unstable capsid tha

140 ement of the photonic inactivation of Murine Leukemia Virus (MLV) via 805 nm femtosecond pulses throu

141 ection by the gammaretrovirus Moloney murine leukemia virus (MLV) was unaffected.

142 perties of the Gag protein of Moloney murine leukemia virus (MLV), a gammaretrovirus.

143 vectors bearing the envelope of 10A1 murine leukemia virus (MLV), a murine retrovirus that can use P

144 For retroviruses such as HIV-1 and murine leukemia virus (MLV), active receptor recruitment and tr

145 simian immunodeficiency virus (SIV), murine leukemia virus (MLV), and the retrotransposon MusD.

146 the generation of pseudotyped HIV-1, murine leukemia virus (MLV), and vesicular stomatitis virus (VS

147 domains in gammaretroviruses, such as murine leukemia virus (MLV), is unique.

148 For simple retroviruses, such as murine leukemia virus (MLV), the identities of the cellular pro

149 lycosylated Gag (glycoGag) protein of murine leukemia virus (MLV), the S2 protein of equine infectiou

150 ations present in a model retrovirus, murine leukemia virus (MLV), using mass spectrometry and sequen

151 We developed a Moloney mouse leukemia virus (MLV)-based retroviral replicating vector

152 n the long terminal repeats (LTRs) of murine leukemia virus (MLV)-based vectors and the vector-specif

153 therapy approaches utilize HIV-1- or murine leukemia virus (MLV)-based vectors, which preferentially

154 odeficiency virus type 1 (HIV-1)- and murine leukemia virus (MLV)-derived viral vectors, respectively

155 e a newly appreciated viral target in murine leukemia virus (MLV)-induced neurodegeneration.

156 The association of xenotropic murine leukemia virus (MLV)-related virus (XMRV) in prostate ca

157 related virus (XMRV) as well as other murine leukemia virus (MLV)-related viruses, though not all stu

158 to support the replication of Moloney murine leukemia virus (MLV).

159 T lymphocytes are natural targets of murine leukemia virus (MLV).

160 by most gammaretroviruses, including murine leukemia virus (MLV).

161 monkey virus (M-PMV) but not Moloney murine leukemia virus (MLV).

162 Certain murine leukemia viruses (MLVs) are capable of inducing fatal pr

163 Mouse leukemia viruses (MLVs) are found in the common inbred s

164 Many murine leukemia viruses (MLVs) are partially resistant to restr

165 Laboratory mice carry mouse leukemia viruses (MLVs) of three host range groups which

166 irus-induced leukemogenesis, ecotropic mouse leukemia viruses (MLVs) recombine with nonecotropic endo

167 ers of the gammaretroviruses--such as murine leukemia viruses (MLVs), most notably XMRV [xenotropic m

168 An RNA kissing loop from the Moloney murine leukemia virus (MMLV) exhibits unusual mechanical stabil

169 emplate switching property of Moloney murine leukemia virus (MMLV)-type reverse transcriptases.

170 y inhibits the replication of Moloney murine leukemia virus (Mo-MLV) and is required for the antiretr

171 L complex to newly integrated Moloney murine leukemia virus (Mo-MuLV) proviral DNA.

172 prototypical gammaretrovirus Moloney murine leukemia virus (MoMLV) favors strong enhancers and activ

173 reverse transcriptase (RT) of Moloney murine leukemia virus (MoMLV) is expressed in the form of a lar

174 The Moloney murine leukemia virus (MoMLV) ribonucleoprotein complex is comp

175 t not the RNase H function of Moloney Murine Leukemia Virus (MoMLV) RT and also inhibited Escherichia

176 that tetherin does not affect Moloney murine leukemia virus (MoMLV) spread, and only minimally affect

177 What role does myeloproliferative leukemia virus (MPL), a key regulator of adult megakaryo

178 calreticulin (CALR), and myeloproliferative leukemia virus (MPL), abnormally activate the cytokine r

179 gainst clade C HIV-1 gp140, gp120, or murine leukemia virus (MuLV) gp70-scaffolded V1/V2 and toward b

180 The p12 protein of murine leukemia virus (MuLV) group-specific antigen (Gag) is as

181 arce, femtomole quantities of Moloney murine leukemia virus (MuLV) RNA inside authentic virions and f

182 0.25 mM) and is comparable to Moloney murine leukemia virus (MuLV) RT fidelity.

183 High expression of murine leukemia virus (MuLV) transcripts was observed in DEL ce

184 mouse mammary tumor virus (MMTV) and murine leukemia virus (MuLV) via an adaptive immune mechanism,

185 ammaretroviruses, typified by Moloney murine leukemia virus (MuLV), gag and pol are in the same readi

186 rus 1 (Bxv1), a xenotropic endogenous murine leukemia virus (MuLV), is present in these 2 recently de

187 wild-type (WT) or Mll-AF9 mice with a murine leukemia virus (MuLV).

188 found to also contain reads from the murine leukemia virus (MuLV).

189 the mechanism of APOBEC inhibition of murine leukemia viruses (MuLVs) does not appear to be G-->A hyp

190 with mixtures of mouse retroviruses (murine leukemia viruses [MuLVs]) exhibit dramatically altered p

191 For the restriction of N-tropic murine leukemia virus (N-MLV) and equine infectious anemia viru

192 , we had previously selected N-tropic murine leukemia virus (N-MLV) mutants escaping from rhesus maca

193 man TRIM5alpha inhibition of N-tropic murine leukemia virus (N-MLV).

194 Calreticulin (CALR) and myeloproliferative leukemia virus oncogene (MPL) mutations are specific to

195 calreticulin (CALR), and myeloproliferative leukemia virus oncogene (MPL) mutations; respective freq

196 ng via the thrombopoietin/myeloproliferative leukemia virus oncogene (MPL) pathway and impaired propl

197 Thrombopoietin (Thpo)/myeloproliferative leukemia virus oncogene (Mpl) signaling controls hematop

198 cellular homologue of the myeloproliferative leukemia virus oncogene (Mpl), is the major cytokine reg

199 LNK deficiency increases myeloproliferative leukemia virus oncogene signaling and AKT activation, wh

200 t promotes thrombopoietin/myeloproliferative leukemia virus oncogene signaling and platelet and leuko

201 NK function and increased myeloproliferative leukemia virus oncogene signaling.

202 , including JAK2 exon 12, myeloproliferative leukemia virus oncogene, LNK (also known as SH2B3) mutat

203 The myeloproliferative leukemia virus oncogene, MPL, a homodimeric receptor act

204 ignaling via its receptor myeloproliferative leukemia virus oncogene.

205 hibits the replication of HIV but not murine leukemia virus or chikungunya virus.

206 oad windows of small RNA sizes in the bovine leukemia virus ovine model of leukemia/lymphoma, we prov

207 provirus integration site for Moloney murine leukemia virus (Pim) 1 kinase is an oncogenic serine/thr

208 proviral integration site for Moloney murine leukemia virus (PIM) 1, 2, and 3 kinases in a NF-kappaB-

209 Proviral integration site for Moloney murine leukemia virus (Pim) kinases are serine/threonine/tyrosi

210 proviral integration site for Moloney murine leukemia virus (PIM) kinases PIM1 and PIM2 have been imp

211 ugh active heme export by the group C feline leukemia virus receptor (FLVCR).

212 S has been associated with xenotropic murine leukemia virus-related virus (XMRV) as well as other mur

213 Xenotropic murine leukemia virus-related virus (XMRV) has been found in th

214 Although xenotropic murine leukemia virus-related virus (XMRV) has been previously

215 The discovery of xenotropic murine leukemia virus-related virus (XMRV) in human tissue samp

216 Xenotropic murine leukemia virus-related virus (XMRV) infection was incorr

217 We analyzed xenotropic murine leukemia virus-related virus (XMRV) integration site seq

218 Xenotropic murine leukemia virus-related virus (XMRV) is a gammaretrovirus

219 Xenotropic murine leukemia virus-related virus (XMRV) is a gammaretrovirus

220 Xenotropic murine leukemia virus-related virus (XMRV) was first identified

221 Xenotropic murine leukemia virus-related virus (XMRV) was previously repor

222 irus type-1 (HIV-1) and of xenotropic murine leukemia virus-related virus (XMRV), a gammaretrovirus t

223 thentic genomic RNA of the xenotropic murine leukemia virus-related virus (XMRV).

224 The retrovirus XMRV (xenotropic murine leukemia virus-related virus) has been detected in human

225 a retrovirus called XMRV (xenotropic murine leukemia virus-related virus) was present in the blood o

226 xpectedly high levels of m(5)C in the murine leukemia virus RNA, precisely mapped its location, and s

227 These compounds also inhibit Moloney murine leukemia virus RT but not the Klenow fragment of Escheri

228 cation in vivo, I constructed a novel murine leukemia virus strain (FMLV-IL-1beta) that encodes the m

229 Feline leukemia virus subgroup C cellular receptor 1a (FLVCR1a)

230 The feline leukemia virus subgroup C receptor (FLVCR) is a 12-trans

231 et al. reveal that an isoform of the feline leukemia virus subgroup C receptor (FLVCR1) exports heme

232 mRNA expression of the heme exporter feline leukemia virus subgroup C receptor 1 (beta = -0.30; P =

233 Feline leukemia virus subgroup C receptor 1 (FLVCR1) is a cell

234 Using Abelson murine leukemia virus-transformed B cells to model this stage o

235 during clonal expansion using Abelson murine leukemia virus-transformed B cells.

236 portant human pathogens such as human T-cell leukemia virus type 1 (HTLV-1) and HIV-1.

237 Human T-cell leukemia virus type 1 (HTLV-1) and HTLV-2 are closely re

238 chniques in real time with both human T-cell leukemia virus type 1 (HTLV-1) and human immunodeficienc

239 Human T-cell leukemia virus type 1 (HTLV-1) and type 2 (HTLV-2) are h

240 Human T-cell leukemia virus type 1 (HTLV-1) and type 2 (HTLV-2) are h

241 report that vaccination against human T-cell leukemia virus type 1 (HTLV-1) basic leucine zipper (bZI

242 Infection with human T-cell leukemia virus type 1 (HTLV-1) can cause a rare form of

243 o HTLV-1 infectivity.IMPORTANCE Human T-cell leukemia virus type 1 (HTLV-1) causes a variety of disea

244 Human T-cell leukemia virus type 1 (HTLV-1) causes multiple pathologi

245 tegrated form of the retrovirus human T-cell leukemia virus type 1 (HTLV-1) contains identical DNA se

246 Human T-cell leukemia virus type 1 (HTLV-1) establishes a lifelong in

247 Human T-cell leukemia virus type 1 (HTLV-1) expression depends on the

248 Human T-cell leukemia virus type 1 (HTLV-1) has two late domain (LD)

249 Human T-cell leukemia virus type 1 (HTLV-1) infection and transformat

250 Human T cell leukemia virus type 1 (HTLV-1) inhibits host antiviral s

251 Human T-cell leukemia virus type 1 (HTLV-1) is a complex retrovirus a

252 Human T-cell leukemia virus type 1 (HTLV-1) is a retrovirus, and, as

253 Human T-cell leukemia virus type 1 (HTLV-1) is an oncogenic retroviru

254 The particle structure of human T-cell leukemia virus type 1 (HTLV-1) is poorly characterized.

255 Human T-cell leukemia virus type 1 (HTLV-1) is the causative agent of

256 Human T-cell leukemia virus type 1 (HTLV-1) is the causative agent of

257 The complex retrovirus human T-cell leukemia virus type 1 (HTLV-1) is the causative agent of

258 Human T cell leukemia virus type 1 (HTLV-1) is the ethological agent

259 Human T-cell leukemia virus type 1 (HTLV-1) is the etiological agent

260 kawa et al demonstrate that the human T-cell leukemia virus type 1 (HTLV-1) oncoprotein Tax induces a

261 present study, we show that the Human T-cell Leukemia Virus Type 1 (HTLV-1) oncoprotein Tax is a subs

262 d to be largely dispensable for human T-cell leukemia virus type 1 (HTLV-1) particle biogenesis.

263 Human T-cell leukemia virus type 1 (HTLV-1) propagates within and bet

264 The role of autophagy in human T-cell leukemia virus type 1 (HTLV-1) replication has, however,

265 The human T-cell leukemia virus type 1 (HTLV-1) Tax oncoprotein actively

266 t of humanized mice infected by human T-cell leukemia virus type 1 (HTLV-1) that recapitulate adult T

267 The glycoproteins from human T-cell leukemia virus type 1 (HTLV-1) were resistant to the ant

268 In comparison, NC of human T-cell leukemia virus type 1 (HTLV-1), a deltaretrovirus, displ

269 Human T cell leukemia virus type 1 (HTLV-1), also known as human T ly

270 retroviral oncoprotein Tax from human T-cell leukemia virus type 1 (HTLV-1), an etiological factor th

271 found that HBZ, encoded by the Human T-cell Leukemia Virus type 1 (HTLV-1), binds to multiple domain

272 on by HIV-1, HIV-1Deltavif, and human T-cell leukemia virus type 1 (HTLV-1), while significantly inhi

273 ptosis, we used TRAIL-resistant human T cell leukemia virus type 1 (HTLV-1)-associated adult T cell l

274 Human T-cell leukemia virus type 1 (HTLV-1)-associated adult T-cell l

275 to the total viral burden in 22 human T cell leukemia virus type 1 (HTLV-1)-infected individuals by a

276 Disease development in human T-cell leukemia virus type 1 (HTLV-1)-infected individuals is p

277 ion with the complex retrovirus human T-cell leukemia virus type 1 (HTLV-1).

278 ive T-cell malignancy caused by human T-cell leukemia virus type 1 (HTLV-1).

279 Human T-cell leukemia virus type 1 (HTLV-I) is associated with adult

280 Human T cell leukemia virus type 1 and type 2 (HTLV-1 and -2) are two

281 Tax oncoprotein encoded by the human T-cell leukemia virus type 1 plays a pivotal role in viral pers

282 ions in three viral infections: Human T cell Leukemia Virus type 1, Human Immunodeficiency Virus type

283 Human T-cell leukemia virus type 1-associated adult T-cell leukemia/l

284 Human T-cell leukemia virus type 1-infected cells proliferate faster

285 Moloney leukemia virus type 10 protein (MOV10) is an RNA helicas

286 s in the transplant population: human T-cell leukemia virus type 1; hepatitis E virus; bocavirus; KI

287 Human T-cell leukemia virus type I (HTLV-1) replication relies on the

288 The Human T-cell leukemia virus type I (HTLV-I) is the only known transfo

289 atological malignancy caused by human T-cell leukemia virus type-1 (HTLV-1).

290 cogenic delta(delta)-retrovirus human T-cell leukemia virus type-1 (HTLV-1).

291 Human T cell leukemia virus, type 1 (HTLV-1) replication and spread a

292 Human T-cell leukemia virus types 3 and 4 (HTLV-3 and HTLV-4) are rec

293 Stavrou et al. (2015) reveal how the murine leukemia virus uses a sugar-protein shield to protect fr

294 TM cleavage in Moloney murine leukemia virus was inhibited by amprenavir, and the Envs

295 with the C terminus of Tax-1 of human T-cell leukemia virus with micromolar affinity.

296 e APOBEC3 protein blocks infection by murine leukemia viruses without catalyzing this base change, an

297 nonpermissive to XMRV and xenotropic murine leukemia virus (X-MLV) infection, suggesting that the xe

298 (MLVs), most notably XMRV [xenotropic murine leukemia virus (X-MLV)-related virus--have been reported

299 The xenotropic and polytropic mouse leukemia viruses (X-MLVs and P-MLVs, respectively) have

300 Xenotropic mouse leukemia viruses (X-MLVs) are broadly infectious for mam

301 e leukemia virus (MLV) and xenotropic murine leukemia virus (XMRV), named the CAE (cytoplasmic accumu